Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LW231 in Chronic Hepatitis B
NCT07179575Phase 2Recruiting
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Start
- Nov 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LW231 in Chronic Hepatitis B (CHB), sponsored by Shanghai Longwood Biopharmaceuticals Co., Ltd.. Started Nov 2025; status: recruiting.
02
Drugs
LW231
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07179575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07179575.